Chen Tao, Guo Zai-Pei, Wang Wen-Ju, Fu Li-Xin, Sun Qiao-Mei, Zhou Pei-Mei
Department of Dermato-Venereology, Chengdu Second People's Hospital, Chengdu, Sichuan, China.
Department of Dermato-Venereology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Ann Allergy Asthma Immunol. 2017 Jun;118(6):704-709. doi: 10.1016/j.anai.2017.04.013.
Chronic spontaneous urticaria (CSU) is a common skin disease characterized by recurrent itchy wheals with or without angioedema that lasts longer than 6 weeks. Vascular endothelial (VE)-cadherin is an endothelial cell-specific adhesion molecule that plays critical roles in angiogenesis and endothelial permeability.
To investigate serum levels of soluble VE (sVE)-cadherin in patients with CSU.
Serum levels of sVE-cadherin in patients with CSU, patients with atopic dermatitis, and healthy controls were determined by enzyme-linked immunosorbent assay. In addition, changes in sVE-cadherin serum levels were compared in patients with CSU before and after H antihistamine treatment. Furthermore, the effects of histamine on sVE-cadherin release by HMEC-1 cells were determined by enzyme-linked immunosorbent assay. The inhibition effects of H antihistamine and H antihistamine on sVE-cadherin release, VE-cadherin phosphorylation, and VE-cadherin disruption were evaluated in histamine-treated HMEC-1 cells by western blot and immunofluorescence.
Serum levels of sVE-cadherin in patients with CSU were significantly higher than those in patients with atopic dermatitis and healthy controls. Serum sVE-cadherin levels in patients with CSU were correlated with the severity of CSU according to Urticaria Activity Scores. Furthermore, serum sVE-cadherin levels in patients with CSU at pretreatment decreased after H antihistamine treatment. In addition, histamine markedly induced sVE-cadherin release in HMEC-1 cells. Moreover, H antihistamine, but not H antihistamine, significantly inhibited sVE-cadherin release in histamine-treated HMEC-1 cells. Western blot data showed that histamine induced phosphorylation of VE-cadherin in HMEC-1 cells, which was blocked by H antihistamine.
The present data showed serum levels of sVE-cadherin are increased in patients with CSU. Histamine-induced sVE-cadherin release from endothelial cells could play a role in the pathogenesis of CSU.
慢性自发性荨麻疹(CSU)是一种常见的皮肤病,其特征为反复出现瘙痒性风团,伴或不伴有血管性水肿,持续时间超过6周。血管内皮(VE)-钙黏蛋白是一种内皮细胞特异性黏附分子,在血管生成和内皮通透性中起关键作用。
研究CSU患者血清可溶性VE(sVE)-钙黏蛋白水平。
采用酶联免疫吸附测定法测定CSU患者、特应性皮炎患者和健康对照者血清sVE-钙黏蛋白水平。此外,比较了CSU患者在H抗组胺药治疗前后sVE-钙黏蛋白血清水平的变化。此外,通过酶联免疫吸附测定法确定组胺对HMEC-1细胞释放sVE-钙黏蛋白的影响。通过蛋白质印迹法和免疫荧光法评估H抗组胺药和H抗组胺药对组胺处理的HMEC-1细胞中sVE-钙黏蛋白释放、VE-钙黏蛋白磷酸化和VE-钙黏蛋白破坏的抑制作用。
CSU患者血清sVE-钙黏蛋白水平显著高于特应性皮炎患者和健康对照者。根据荨麻疹活动评分,CSU患者血清sVE-钙黏蛋白水平与CSU严重程度相关。此外,CSU患者治疗前血清sVE-钙黏蛋白水平在H抗组胺药治疗后降低。此外,组胺显著诱导HMEC-1细胞释放sVE-钙黏蛋白。此外,H抗组胺药而非H抗组胺药显著抑制组胺处理的HMEC-1细胞中sVE-钙黏蛋白的释放。蛋白质印迹数据显示,组胺诱导HMEC-1细胞中VE-钙黏蛋白磷酸化,而H抗组胺药可阻断该磷酸化。
目前的数据表明,CSU患者血清sVE-钙黏蛋白水平升高。组胺诱导内皮细胞释放sVE-钙黏蛋白可能在CSU发病机制中起作用。